| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/2006 | EP1073648B1 12,13-modified epothilone derivatives |
| 09/20/2006 | EP1056700B1 Medicinal uses of phenylalkanols and derivates |
| 09/20/2006 | EP1037611A4 Biodegradable mixed polymeric micelles for gene delivery |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | EP0929569B1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | EP0914153B1 Multivalent dtp-polio vaccines |
| 09/20/2006 | EP0904339B2 Sterol extraction with a polar solvent to give low sterol microbial oil |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/20/2006 | EP0799037B1 Compositions for treating allergic rhinitis and other disorders comprising descarboethoxyloratadine |
| 09/20/2006 | CN1836042A Conserved HBV and HCV sequences useful for gene silencing |
| 09/20/2006 | CN1835964A Target-oriented chemotherapy for treating tumors of the sexual organs |
| 09/20/2006 | CN1835963A Stabilized immunomodulatory oligonucleotides |
| 09/20/2006 | CN1835962A Compositions and methods for treatment of disease with acetylated disaccharides |
| 09/20/2006 | CN1835956A Acylated and non-acylated imidazo [2,1-b]-1, 3, 4,-thiadiazole-2-sulfonamides, and uses thereof |
| 09/20/2006 | CN1835953A 4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists |
| 09/20/2006 | CN1835952A Compounds and compositions as inhibitors of receptor tyrosine kinase activity |
| 09/20/2006 | CN1835951A Isethionate salt of a selective CDK4 inhibitor |
| 09/20/2006 | CN1835950A Imidazopyridine derivatives |
| 09/20/2006 | CN1835949A Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors |
| 09/20/2006 | CN1835948A 2-acylaminothiazole derivative or its salt |
| 09/20/2006 | CN1835947A Novel oxazoles, their manufacture and use as pharmaceutical agents |
| 09/20/2006 | CN1835945A Chinazoline derivatives as aurora kinase inhibitors |
| 09/20/2006 | CN1835944A Quinolyl amide derivatives as CCR-5 antagonists |
| 09/20/2006 | CN1835943A 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/20/2006 | CN1835942A Mucin synthesis inhibitors |
| 09/20/2006 | CN1835940A Chromen-4-one derivatives |
| 09/20/2006 | CN1835938A Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 09/20/2006 | CN1835937A Novel thiazoline derivatives as selective androgen receptor modulators (SARMS) |
| 09/20/2006 | CN1835936A Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/20/2006 | CN1835935A Stable polymorph of bifeprunox mesilate |
| 09/20/2006 | CN1835934A Oxazole derivatives as inhibitors of cyclooxygenase |
| 09/20/2006 | CN1835931A Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CFR antagonists |
| 09/20/2006 | CN1835929A 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 09/20/2006 | CN1835928A Pyrimidinone compounds as calcilytics |
| 09/20/2006 | CN1835926A Process for the preparation of nonpeptide substituded spirobenzoazepine derivatives |
| 09/20/2006 | CN1835925A Substituted spirobenzazepines |
| 09/20/2006 | CN1835924A Fused compounds that inhibit vanilloid receptor subtype 1(vr1) receptor |
| 09/20/2006 | CN1835922A Process for preparation of 4-aryl-nicotinamide derivatives |
| 09/20/2006 | CN1835921A N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 09/20/2006 | CN1835920A Potassium or sodium salt of (-)-2-([2-(4-hydroxyphenyl)ethyl]thio)-3-[4-(2-(4-[(methylsulfonyl)oxy]phenoxy)ethyl)phenyl]-propanoic acid and their use in medicine |
| 09/20/2006 | CN1835919A Amine salts of (-)-2-([2-(4-hydroxyphenyl)ethyl]thio)-3-[4-(2-(4-[(methylsulfonyl)oxy]phenoxy)ethyl)phenyl]propanoic acid and their use in medicine |
| 09/20/2006 | CN1835918A Process for the preparation of racemic 2-[[2-(4-hydroxyphenyl)ethyl]thio]-3-[4-(2-[4-[(methylsulfonyl)oxy]phenoxy]ethyl)phenyl]-propanoic acid |
| 09/20/2006 | CN1835917A Therapeutic agents |
| 09/20/2006 | CN1835916A 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders |
| 09/20/2006 | CN1835914A New benzamides as PPAR[upsilon] modulators |
| 09/20/2006 | CN1835913A Propionic acid derivatives useful in the treatment of lipid disorders |
| 09/20/2006 | CN1835912A Crystalline form of nateglinide |
| 09/20/2006 | CN1835770A Pharmaceutical compositions |
| 09/20/2006 | CN1835765A Method of treating viral infections |
| 09/20/2006 | CN1835762A Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 09/20/2006 | CN1835761A Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilisation of glycemia |
| 09/20/2006 | CN1835760A Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 09/20/2006 | CN1835758A Glycyrrhizin high-concentration preparation |
| 09/20/2006 | CN1835757A Compositions comprising ZD6126 together with 5-FU, CPT-11 or 5-FU and CPT-11 having vascular damaging activity for treating e.g. colorectal cancer |
| 09/20/2006 | CN1835756A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 09/20/2006 | CN1835755A Gsk－3抑制剂及其用途 Gsk-3 inhibitors and their use |
| 09/20/2006 | CN1835754A Stable medical freeze dried preparation of tetraodotoxin |
| 09/20/2006 | CN1835753A Spiro tetrahydroquinazolines and dihydrocyclopentapyrimidines as CFR antagonists |
| 09/20/2006 | CN1835752A Multivitamin syrup for children or young adults |
| 09/20/2006 | CN1835751A Therapeutic agents useful for treating pain |
| 09/20/2006 | CN1835750A Oxime substituted imidazo-containing compounds |
| 09/20/2006 | CN1835749A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 09/20/2006 | CN1835748A Use of cyclopamine in the treatment of psoriasis and other skin disorders |
| 09/20/2006 | CN1835747A Use of 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 09/20/2006 | CN1835746A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 09/20/2006 | CN1835745A Omega-3 fatty acids for the treatment of canine ostheoarthritis |
| 09/20/2006 | CN1835744A Remedy for viral disease |
| 09/20/2006 | CN1835743A Compounds for the treatment of metabolic disorders |
| 09/20/2006 | CN1835742A Preparing method for controlled released type tablet tamsulosin hcl and the tablet thereof |
| 09/20/2006 | CN1835741A Novel composition comprising rosiglitazone and another antidiabetic agent |
| 09/20/2006 | CN1835740A Pharmaceutical compositions and methods for the prevention of breast and ovarian cancer |
| 09/20/2006 | CN1835739A Hexameric porphobilinogen synthase as a target for the development of antibiotics and herbicides |
| 09/20/2006 | CN1835738A Pharmaceutical compositions having a swellable coating |
| 09/20/2006 | CN1835737A Pharmaceutical formulation for contraception and hormone-replacement therapy |
| 09/20/2006 | CN1835735A Drug delivery system for administering fine particle under tenon's capsule |
| 09/20/2006 | CN1835722A Transdermal hormone delivery system: compositions and methods |
| 09/20/2006 | CN1834109A Cross-linked pachyman, its prepn. and uses |
| 09/20/2006 | CN1834108A Acanthopanax giraldii Harms compound polysaccharide, prepn. technique, uses and its compound polysaccharide compsns. |
| 09/20/2006 | CN1834106A Fermenting free hydralysis process for extracting saporin from yellow ginger |
| 09/20/2006 | CN1834104A Lactose with first anti-adhesion activity and its fluorescent mark |
| 09/20/2006 | CN1834096A Process of preparing sophoridine, oxidized sophoridine and salts from sophora alopecuroide |
| 09/20/2006 | CN1834095A Nonnucleoside antivirus inhibitor, its prepn. and use |
| 09/20/2006 | CN1834091A Sustituted Gly derivative for treating diabetes and adiposis |
| 09/20/2006 | CN1834088A Tetrapeptide derivative crystals |
| 09/20/2006 | CN1834087A Organo-iodine complex |
| 09/20/2006 | CN1833722A Health products for face care and body care |
| 09/20/2006 | CN1833693A Red medicine gel for treating traumatic injury and its prepn. method |
| 09/20/2006 | CN1833691A Externally used Chinese patent medicine for treating colpomycosisor tricho monal vaginitis, and prepn. method |
| 09/20/2006 | CN1833685A Chinese medicinal compsns. for treating burn and scald, its prepn. and usage |
| 09/20/2006 | CN1833681A 'Senwei' anti-cancer capsules and its prepn. process |
| 09/20/2006 | CN1833674A Wart gel and prepn. method |
| 09/20/2006 | CN1833668A Medicinal compsns. having cooperative action |
| 09/20/2006 | CN1833657A Compound preparation for prevention and treatment adiposis and its prepn. method |
| 09/20/2006 | CN1833656A Cyclic AMP injecta and its prepn. process |
| 09/20/2006 | CN1833655A Sodium triphosphate transfusion and its prepn. technique |
| 09/20/2006 | CN1833654A Composition of figwortfower picrorhiza rhizome iridoid total glucoside and nucleoside medicine for treating virus hepatitis |
| 09/20/2006 | CN1833653A Application and prepn. process of shiyacha total flavone |
| 09/20/2006 | CN1833652A Sustained release composns preparation of Fudosteine and clarithromycin |
| 09/20/2006 | CN1833651A Xindakang drip pill and prepn. thereof |